Outcomes of Giliteritinib in R/R AML with FLT3 Positive Mutation
Speaker: Dr. Pau Montesinos Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.
Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022
Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020
Speaker: Dr. Dan Douer Affiliations: Associate Professor of Medicine in the Division of Hematology, University of Southern California, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.